Pozen Inc: (NASD: POZN)

$4.93

0.03 (0.61%)

Volume 111,364

May 23 04:00 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 4.89 - 5.02
52wk Low - High 4.26 - 7.55
Previous Close 4.90
Avg. Volume 228,135
Industry MED-DRUGS
Market Cap 148.70 M
Div - Yield 0.00 - 0.00
Beta 1.38
PE (Forward) 0.00
Current Year Est. -0.34
Quarterly Earnings ESP 0.00%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

3

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

NA

Zacks Industry Rank

106 out of 265

Equity Research Report

Updated as of NA

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

PE (Forward) NA
PEG Ratio NA
Current Year Est. -0.34
Current Quarter Estimate -0.21
Most Accurate Estimate -0.21
Earnings ESP 0.00%
Next Earnings Report Date 08-07-2013
EPS Last Year -0.75
Expected Earnings Growth NA

Company Description

Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine, where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100, which the company is developing as an oral first-line therapy for the treatment of migraine.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

POZN Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate -0.21 -0.21 -0.34 0.18
Number of Estimates 3 3 3 2
Low Estimate -0.22 -0.21 -0.81 0.18
High Estimate -0.19 -0.20 0.47 NA
Year Ago EPS -0.17 -0.19 -0.84 -0.34
EPS Growth -21.57% -8.77% 59.92% 153.47%

Average Earnings Estimates for POZN

EPS Growth for POZN

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
POZEN INC POZN 4.90
JAZZ PHARMACEUT JAZZ 61.53
SALIX PHARM-LTD SLXP 59.47
SANTARUS INC SNTS 22.28
USANA HLTH SCI USNA 68.14
CATALYST PHARMA CPRX 0.85
CELL THERAPEUT CTIC 1.29
CUBIST PHARM CBST 56.11
ELAN CP PLC ADR ELN 12.04
INFINITY PHARMA INFI 23.12

Sector:Medical>> Industry:MED-DRUGS

COMPARE TICKER vs. Its Peers

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.